Corrigendum to “The KEEPER™1 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study” [Epilepsy Res. 54 (2003) 153–162]

Corrigendum Corrigendum to “The KEEPERTM1 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study” [Epilepsy Res. 54 (2003) 153–162] M.J. Morrell a,∗, I. Leppik b, J. French c, J. Ferrendelli d, J. Han e, L. Magnus e a The Neurological Institute, Columbia Presbyterian Medical Center, Columbia University, 710 West 168th Street, New York, NY, USA b MINCEP Epilepsy Care, Minneapolis, MN, USA c Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA d Department of Neurology, School of Medicine, University of Texas-Houston, Houston, TX, USA e UCB Pharma, Inc., Smyrna, GA, USA